Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel Combinations vs Cisplatin/5-FU in SCCHN
NCT00401323Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jan 1998
- Primary completion
- Jun 2003
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Sanofi. Started Jan 1998; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00401323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401323.